检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:王瑞[1]
出 处:《眼科新进展》2009年第8期611-613,共3页Recent Advances in Ophthalmology
摘 要:目的评价双切口白内障超声乳化吸除、人工晶状体植入联合小梁切除术(三联术)治疗青光眼合并白内障的疗效与安全性。方法回顾性分析2008年1月至2008年12月我院行双切口三联术的青光眼合并白内障患者47例(52眼),观察手术前后的视力、眼压、并发症,随访3~6个月。结果术后42眼视力提高,14眼视力<0.1,27眼视力为0.1~0.4,11眼视力≥0.5,术前、术后比较差异有显著统计学意义(Z=-5.399,P=0.000)。术后眼压平均为(12.59±4.33)mmHg(1kPa=7.5mm-Hg),术前、术后比较差异有显著统计学意义(t=13.453,P=0.000),其中47眼眼压未采取措施控制良好。术中、术后3眼发生浅前房,其中2眼为脉络膜脱离所致,余无其他严重并发症。结论双切口三联术治疗青光眼合并白内障是安全、有效的。Objective To evaluate the therapeutic effects and safety of two-incision phacoemuisification and IOL implantation combined with trabeculectomy (triple surgery) in the treatment of glaucoma combined with cataract. Methods A total of 47 cases (52 eyes) with glaucoma and cataract, who performed with two-incision triple surgery from January 2008 to December 2008 in our hospital, were retrospectively analyzed. Preoperative and postoperative visual acuity, IOP and complications were observed, and all cases were followed up for 3 to 6 months. Results Postoperative visual acuity improved in 42 eyes, Postoperative visual acuity less than 0.1 was in 14 eyes, between 0.1 and 0.4 was in 27 eyes, and be or more than 0.5 was in 11 eyes. There was significant difference between pre- and post-operation( Z = - 5.399 ,P = 0.000) ; Postop- erative mean IOP was ( 12.59 +4.33) mmHg( 1 kPa =7.5 mmHg) ,and there was significant difference between pre= and post-operation (t = 13. 453, P = 0. 000). Forty-seven eyes controlled IOP well without any other treatments ,3 eyes were with shallow anteri- or chamber intraoperatively and postoperatively,2 eyes of which were induced by choroidal detachment. No other serious complication was found. Conclusion Two-incision triple surgery is safe and effective in the treatment of glaucoma combined with cataract.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.54